The human microbiome market consists of products and
technologies that are utilized for analyzing, identifying, monitoring and
modifying the microbiota in or on the human body. This includes products such
as reagents, instruments and kits as well as software and analytical services
for carrying out research related to microbiota and their role in human health
and disease. The human microbiome is gaining increased attention due to its
significant impact on overall health and well-being of individuals.
Advancements in sequencing technologies and bioinformatics are enabling comprehensive
characterization of human microbiota and their functions. The market is
witnessing growing demand for microbiome-based therapies, diagnostics,
prebiotics and supplements for applications across various disease areas such
as gastrointestinal, metabolic and neurodegenerative disorders.
The
Global human microbiome market is estimated to be valued at US$ 4894.33 Mn in
2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to
2031.
Key Takeaways
Key players operating in the human microbiome market are Diageo plc,
Pernod-Ricard SA, Constellation Brands Inc., Brown-Forman Corporation, Remy
Cointreau SA, Marie Brizard Wine & Spirits, Lapostolle SA, and
Berentzen-Gruppe AG. These players are focusing on new product launches, partnerships,
mergers and acquisitions to gain market share. For instance, in 2022, Diageo
acquired Chase Distillery to expand its presence in the premium spirits
category.
Some of the key opportunities in the
Human
Microbiome Market Demand include growing demand for microbiome-based
drugs and therapies. Factors such as increasing prevalence of chronic diseases,
growing geriatric population and improved regulatory guidelines are fueling
research and development activities for developing microbiome-based therapies.
Currently, microbiome-based therapeutics are under clinical trials for various
indications such as colitis, antibiotic-resistant infections and cardiovascular
diseases.
The human microbiome market has huge growth potential in emerging economies of
Asia Pacific and Latin America. Major players are focusing on establishing
sales and distribution networks as well as collaborating with regional research
institutes and startups to tap into new geographic markets. For example, in
2023, Constellation Brands partnered with a Chinese e-commerce company to
strengthen its portfolio in the largest premium drinks market.
Market Drivers
Rising applications of microbiome therapies across disease areas:
Advancements in microbiome research have enabled discovery of relationships
between microbiota composition and various health conditions. This is driving
demand for microbiome-based therapeutics and probiotic supplements for numerous
medical applications.
Market Restraints
Complexities in commercialization of microbiome products: Despite ongoing
extensive research, development and clinical evaluation of microbiome-based
products, only a few therapeutics have reached commercialization stage. Factors
such as need for representative cultures, product shelf life issues and
formulation challenges are restricting rapid commercialization of microbiome
products.
Segment Analysis
The human microbiome market can be broadly segmented into two major
categories based on products - probiotics and prebiotics. Within probiotics,
Bifidobacterium is currently dominating the market owing to its various health
benefits such as regulation of bowel movements, production of vitamins, enhancement
of nutrient absorption, synthesis of amino acids, and protection against
harmful bacteria and pathogens. Bifidobacterium has gained wider acceptance
among consumers due to increasing awareness related to its benefits.
Within prebiotics, β-glucans currently hold the largest share of the prebiotics
market. β-glucans promote the growth of beneficial bacteria in the gut and
support digestive health. They are found naturally in foods like oats, barley
and mushrooms. Wide usage of β-glucans as a functional ingredient in various
food and beverage products is driving its dominance in the prebiotics segment.
Global Analysis
On the basis of geography, North America is projected to dominate the human
microbiome market during the forecast period. Increased R&D activities
related to gut health, rising consumer awareness about probiotics and
prebiotics, growing incidence of lifestyle diseases, and advanced healthcare
infrastructure are some of the major factors accounting for North America's
large share. However, the Asia Pacific region is anticipated to grow at the
fastest pace owing to the growing geriatric population, increasing healthcare
spending, rising disposable incomes, and growing consumption of functional food
and supplements in countries like China, India and Japan.
Get
more insights on Human
Microbiome Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold
in the market research industry. She specializes in writing well-researched
articles from different industries, including food and beverages, information
and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment